Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study-Reference-Cited by-同舟云学术

Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study

Published:2006-03-09 Issue:14 Volume:13 Page:1110-1117
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Yang S-H,Lee C-G,Park S-H,Im S-J,Kim Y-M,Son J-M,Wang J-S,Yoon S-K,Song M-K,Ambrozaitis A,Kharchenko N,Yun Y-D,Kim C-M,Kim C-Y,Lee S-H,Kim B-M,Kim W-B,Sung Y-C

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3302751.pdf

Reference38 articles.

1. de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M . Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630–1635.

2. Lok AS, Heathcote EJ, Hoofnagle JH . Management of hepatitis B: 2000 – summary of a workshop. Gastroenterology 2001; 120: 1828–1853.

3. Chisari FV, Ferrari C . Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29–60.

4. Rehermann B, Lau D, Hoofnagle JH, Chisari FV . Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 1996; 97: 1655–1665.

5. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70: 7092–7102.

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics;International Journal of Molecular Sciences;2023-10-01

2. Strategies for the development of hepatitis B virus vaccines;Oncogenic Viruses;2023

3. Development of therapeutic vaccines for the treatment of diseases;Molecular Biomedicine;2022-12-08

4. Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4+ T cell responses restricted by single HLA class II allotype in an individual;Frontiers in Immunology;2022-07-28

5. Getting to HBV cure: The promising paths forward;Hepatology;2022-02-16